TrialSignal
Clinical trial intelligence report
A Prospective, Randomized, Controlled, Multi-Center Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05945329
Status
RECRUITING
Phase
NA
Sponsor
C. R. Bard
Executive brief
Investment-Ready Snapshot
C. R. Bard is conducting a multi-center, randomized controlled trial to evaluate the safety and effectiveness of the GalaFLEX LITE™ Scaffold in reducing capsular contracture recurrence in breast augmentation patients. The study aims to enroll between 250 and 530 subjects and compares the scaffold's performance against standard surgical procedures.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05945329
Indication
Capsular Contracture Associated With Breast Implant
Modality
medical device
Target
Capsular Contracture After Breast Implant Augmentation
Intervention
GalaFLEX LITE™ Scaffold, Standard surgery
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.